Works matching DE "EFAVIRENZ-emtricitabine-tenofovir (Drug)"
Results: 81
Challenges for Novel Antiretroviral Development in an Era of Widespread tenofovir-disoproxil/lamivudine (or emtricitabine)/dolutegravir availability (TLD) Availability.
- Published in:
- Clinical Infectious Diseases, 2025, v. 80, n. 2, p. 434, doi. 10.1093/cid/ciae361
- By:
- Publication type:
- Article
Theoretical studies on the molecular basis of HIV-1RT/NNRTIs interactions.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2011, v. 26, n. 1, p. 29, doi. 10.3109/14756360903563393
- By:
- Publication type:
- Article
Usefulness of Methadone Plasma Concentration Measurement in Patients Receiving Nevirapine or Efavirenz.
- Published in:
- American Journal of Drug & Alcohol Abuse, 2011, v. 37, n. 4, p. 264, doi. 10.3109/00952990.2011.591465
- By:
- Publication type:
- Article
HIV/AIDS Patients Display Lower Relative Bioavailability of Efavirenz than Healthy Subjects.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 8, p. 531, doi. 10.2165/11592660-000000000-00000
- By:
- Publication type:
- Article
Serum Nevirapine and Efavirenz Concentrations and Effect of Concomitant Rifampicin in HIV Infected Children on Antiretroviral Therapy.
- Published in:
- Indian Pediatrics, 2011, v. 48, n. 12, p. 943, doi. 10.1007/s13312-011-0153-3
- By:
- Publication type:
- Article
De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study.
- Published in:
- HIV Medicine, 2024, v. 25, n. 9, p. 1019, doi. 10.1111/hiv.13655
- By:
- Publication type:
- Article
Trend over time of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).
- Published in:
- HIV Medicine, 2023, v. 24, n. 11, p. 1150, doi. 10.1111/hiv.13525
- By:
- Publication type:
- Article
Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.
- Published in:
- HIV Medicine, 2017, v. 18, n. 6, p. 412, doi. 10.1111/hiv.12518
- By:
- Publication type:
- Article
Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial
- Published in:
- HIV Medicine, 2016, v. 17, n. 7, p. 505, doi. 10.1111/hiv.12349
- By:
- Publication type:
- Article
Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 390, doi. 10.1111/hiv.12345
- By:
- Publication type:
- Article
Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
- Published in:
- HIV Medicine, 2015, v. 16, n. 6, p. 388, doi. 10.1111/hiv.12243
- By:
- Publication type:
- Article
HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium.
- Published in:
- HIV Medicine, 2014, v. 15, n. 4, p. 196, doi. 10.1111/hiv.12100
- By:
- Publication type:
- Article
Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study Pharmacokinetics of two common antiretroviral regimens in older HIV-infected patients: a pilot study.
- Published in:
- HIV Medicine, 2013, v. 14, n. 7, p. 401, doi. 10.1111/hiv.12017
- By:
- Publication type:
- Article
Government use licenses in Thailand: an assessment of the health and economic impacts.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Lack of Effect from a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Either Efavirenz or Lopinavir-Ritonavir.
- Published in:
- Pharmacotherapy, 2011, v. 31, n. 2, p. 158, doi. 10.1592/phco.31.2.158
- By:
- Publication type:
- Article
Generic HIV drugs will widen US treatment net.
- Published in:
- Nature, 2012, v. 488, n. 7411, p. 267, doi. 10.1038/488267a
- By:
- Publication type:
- Article
Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 685
- By:
- Publication type:
- Article
Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 675, doi. 10.1093/jac/dkr491
- By:
- Publication type:
- Article
Plasma concentrations of efavirenz are associated with body weight in HIV-positive individuals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 11, p. 2601, doi. 10.1093/jac/dkr360
- By:
- Publication type:
- Article
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2092
- By:
- Publication type:
- Article
Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 1, p. 184, doi. 10.1093/jac/dkq395
- By:
- Publication type:
- Article
Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 12, p. 2614, doi. 10.1093/jac/dkq369
- By:
- Publication type:
- Article
Anti-HIV Drugs Nevirapine and Efavirenz Affect Anxiety-Related Behavior and Cognitive Performance in Mice.
- Published in:
- Neurotoxicity Research, 2011, v. 19, n. 1, p. 73, doi. 10.1007/s12640-009-9141-y
- By:
- Publication type:
- Article
Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART Initiation.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 4, p. N.PAG, doi. 10.1093/ofid/ofx210
- By:
- Publication type:
- Article
Simultaneous Spectrophotometric Estimation of Tenofovir Disoproxil Fumarate and Lamivudine in Three Component Tablet Formulation Containing Efavirenz.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2010, v. 72, n. 4, p. 527, doi. 10.4103/0250-474X.73926
- By:
- Publication type:
- Article
Optimizing Initial Therapy for HIV Infection.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 8, p. 1154, doi. 10.1093/infdis/jir506
- By:
- Publication type:
- Article
Association of Pharmacogenetic Markers with Premature Discontinuation of First-line Anti-HIV Therapy: An Observational Cohort Study.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 2, p. 246, doi. 10.1093/infdis/jiq043
- By:
- Publication type:
- Article
How big is a macropolycyte?
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 1, p. 1, doi. 10.1111/j.1365-2141.2011.08727.x
- By:
- Publication type:
- Article
Sustained HIV virologic suppression with crushed combination tablets containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide.
- Published in:
- American Journal of Health-System Pharmacy, 2019, v. 76, n. 16, p. 1180, doi. 10.1093/ajhp/zxz132
- By:
- Publication type:
- Article
Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2018, v. 7, n. 3, p. e148, doi. 10.1093/jpids/piy006
- By:
- Publication type:
- Article
Efavirenz, emtricitabine and tenofovir tablets.
- Published in:
- WHO Drug Information, 2010, v. 24, n. 4, p. 323
- Publication type:
- Article
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US.
- Published in:
- ClinicoEconomics & Outcomes Research, 2013, v. 5, p. 437
- By:
- Publication type:
- Article
Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1.
- Published in:
- Annals of Internal Medicine, 2011, v. 154, n. 7, p. 445, doi. 10.7326/0003-4819-154-7-201104050-00316
- By:
- Publication type:
- Article
Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19767
- By:
- Publication type:
- Article
Cost-effectiveness of DTG+ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19605
- By:
- Publication type:
- Article
Durability of FTC/TDF-containing cART regimens in a large cohort of HIV-infected patients seen for care in Italy.
- Published in:
- Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18135
- By:
- Publication type:
- Article
Elvitegravir/cobicistat/emtricitabine/tenofovir DF (Quad) has durable efficacy and differentiated safety compared to efavirenz/emtricitabine/tenofovir DF at week 96 in treatment-naïve HIV-1-infected patients.
- Published in:
- Journal of the International AIDS Society, 2012, v. 15, p. 1, doi. 10.7448/IAS.15.6.18219
- By:
- Publication type:
- Article
Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) plus EFV leads to improved perceptions of treatment: results from the ROCKET 1 study.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P42, doi. 10.1186/1758-2652-13-S4-P42
- By:
- Publication type:
- Article
Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/ Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1-Infected Patients: 156-Week Results From STARTMRK.
- Published in:
- Clinical Infectious Diseases, 2011, v. 53, n. 8, p. 807, doi. 10.1093/cid/cir510
- By:
- Publication type:
- Article
Comparison of HIV Virologic Failure Rates Between Patients with Variable Adherence to Three Antiretroviral Regimen Types.
- Published in:
- AIDS Patient Care & STDs, 2015, v. 29, n. 7, p. 384, doi. 10.1089/apc.2014.0165
- By:
- Publication type:
- Article
Rilpivirine Versus Efavirenz with Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naïve HIV-1-Infected Patients with HIV-1 RNA ≤100,000 Copies/mL: Week 96 Pooled ECHO/THRIVE Subanalysis.
- Published in:
- AIDS Patient Care & STDs, 2014, v. 28, n. 4, p. 168, doi. 10.1089/apc.2013.0310
- By:
- Publication type:
- Article
EFV/FTC/TDF-Associated Hepatotoxicity: A Case Report and Review.
- Published in:
- AIDS Patient Care & STDs, 2013, v. 27, n. 9, p. 493, doi. 10.1089/apc.2013.0008
- By:
- Publication type:
- Article
Patient-Reported Symptoms on the Antiretroviral Regimen Efavirenz/Emtricitabine/Tenofovir.
- Published in:
- AIDS Patient Care & STDs, 2012, v. 26, n. 6, p. 312, doi. 10.1089/apc.2012.0044
- By:
- Publication type:
- Article
Induction of CYP2C19 and CYP3A Activity Following Repeated Administration of Efavirenz in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2012, v. 91, n. 3, p. 475, doi. 10.1038/clpt.2011.249
- By:
- Publication type:
- Article
Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 90, n. 3, p. 406, doi. 10.1038/clpt.2011.129
- By:
- Publication type:
- Article
The Male Genital Tract Is Not a Pharmacological Sanctuary From Efavirenz.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 90, n. 1, p. 151, doi. 10.1038/clpt.2011.99
- By:
- Publication type:
- Article
A Comparison between the Efficiency of Vonavir (Tenofovir-EmtricitabineEfavirenz) and Cobavir (Lamivudine-Zidovudine) with Efavirenz used for HIV Patients in Fasa, Iran.
- Published in:
- Journal of Advanced Biomedical Sciences, 2022, v. 12, n. 3, p. 319, doi. 10.18502/jabs.v12i3.10717
- By:
- Publication type:
- Article
Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults.
- Published in:
- AIDS Research & Treatment, 2012, p. 1, doi. 10.1155/2012/105980
- By:
- Publication type:
- Article
Real-world effectiveness of WHO recommended first-line antiretroviral therapies: a cohort study from a middle-income country.
- Published in:
- AIDS Care, 2023, v. 35, n. 12, p. 1891, doi. 10.1080/09540121.2023.2190954
- By:
- Publication type:
- Article